| Literature DB >> 29670599 |
Abstract
Notwithstanding its mitosporic nature, an improbable morpho-transformation state i. e., sclerotial development (SD), is vaguely known in Aspergillus oryzae. Nevertheless an intriguing phenomenon governing mold's development and stress response, the effects of exogenous factors engendering SD, especially the volatile organic compounds (VOCs) mediated interactions (VMI) pervasive in microbial niches have largely remained unexplored. Herein, we examined the effects of intra-species VMI on SD in A. oryzae RIB 40, followed by comprehensive analyses of associated growth rates, pH alterations, biochemical phenotypes, and exometabolomes. We cultivated A. oryzae RIB 40 (S1VMI: KACC 44967) opposite a non-SD partner strain, A. oryzae (S2: KCCM 60345), conditioning VMI in a specially designed "twin plate assembly." Notably, SD in S1VMI was delayed relative to its non-conditioned control (S1) cultivated without partner strain (S2) in twin plate. Selectively evaluating A. oryzae RIB 40 (S1VMI vs. S1) for altered phenotypes concomitant to SD, we observed a marked disparity for corresponding growth rates (S1VMI < S1)7days, media pH (S1VMI > S1)7days, and biochemical characteristics viz., protease (S1VMI > S1)7days, amylase (S1VMI > nS1)3-7days , and antioxidants (S1VMI > S1)7days levels. The partial least squares-discriminant analysis (PLS-DA) of gas chromatography-time of flight-mass spectrometry (GC-TOF-MS) datasets for primary metabolites exhibited a clustered pattern (PLS1, 22.04%; PLS2, 11.36%), with 7 days incubated S1VMI extracts showed higher abundance of amino acids, sugars, and sugar alcohols with lower organic acids and fatty acids levels, relative to S1. Intriguingly, the higher amino acid and sugar alcohol levels were positively correlated with antioxidant activity, likely impeding SD in S1VMI. Further, the PLS-DA (PLS1, 18.11%; PLS2, 15.02%) based on liquid chromatography-mass spectrometry (LC-MS) datasets exhibited a notable disparity for post-SD (9-11 days) sample extracts with higher oxylipins and 13-desoxypaxilline levels in S1VMI relative to S1, intertwining Aspergillus morphogenesis and secondary metabolism. The analysis of VOCs for the 7 days incubated samples displayed considerably higher accumulation of C-8 compounds in the headspace of twin-plate experimental sets (S1VMI:S2) compared to those in non-conditioned controls (S1 and S2-without respective partner strains), potentially triggering altered morpho-transformation and concurring biochemical as well as metabolic states in molds.Entities:
Keywords: Aspergillus oryzae; VOCs mediated interactions; biochemical phenotypes; exometabolomes; sclerotia development; twin-plate assembly
Year: 2018 PMID: 29670599 PMCID: PMC5893800 DOI: 10.3389/fmicb.2018.00628
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Figure 1An illustrative diagram showing the twin plate assembly. The plate 1 with lid having orifice was inoculated with “strain 1” Aspergillus oryzae RIB 40 (KACC 44967), i.e., S1VMI subjected to VOCs mediated interactions (VMI) with partner strain A. oryzae (S2: KCCM 60345) in plate 2. A control for strain 1 (S1) was maintained without partner strain (S2) in plate 2 of the twin plate assembly apparatus. All experimental procedures were performed for evaluating the effects of VMI in S1VMI in comparison to its control S1 (marked with light gray shaded background), selectively in the context of morpho-transformation phenomenon (sclerotial development—SD) characteristic of strain 1 in the present study.
Figure 2A time-correlated comparative evaluation of (A) culture morphology and SD, (B) growth profiles, (C) media pH variations, (D) protease activity, (E) Amylase activity, (F) DPPH antioxidant assay, (G) ABTS antioxidant assay, for the sclerotia forming A. oryzae RIB 40 (S1VMI and S1). Here, the data represent the mean ± SD of the triplicates representing three biological sets for each sample (S1VMI and S1). The asterisk representation for one-way ANOVA Dunkan-Tukey pair-wise comparison test indicates, **p < 0.01, *p < 0.05.
Figure 3A time-correlated (A) PLS-DA score plot displaying the clustering patterns of metabolomic datasets, (B) heat map representation for the relative fold change levels of significantly discriminant metabolites (VIP > 0.7, p < 0.05), (C) S-plot for OPLS-DA analysis showing the discriminant metabolite biomarkers (VIP > 6, p < 0.05) for 7 days incubated samples, and (D) the heat map showing Pearson's correlation for linearity between detected metabolite patterns and associated biochemical phenotypes, derived from GC-TOF-MS detected primary metabolite datasets for A. oryzae RIB 40 (S1VMI and S1) sample extracts.
Figure 4A time-correlated (A) PLS-DA score plot displaying the clustering patterns of metabolite, and (B) the heat map representation for the relative fold change levels of significantly discriminant metabolites (VIP > 0.7, p < 0.05), derived from UHPLC-LTQ-IT-MS/MS detected secondary metabolite datasets for A. oryzae RIB 40 (S1VMI and S1) sample extracts.
The list of putatively identified significantly discriminant metabolites (VIP > 0.7, p < 0.05) based on PLS-DA datasets obtained through the temporal LC-MS analyses of A. oryzae RIB 40 (S1VMI and S1) sample extracts.
| 1 | 9.42 | UCT 1072M1 (Anthraquinone furan derivative) | 355 | 357 | 356 | (–)355 > 311 > 293, 283, 269, 268, 266 > 249; (+)357 > 339 > 297 > 269, 255, 241, 213, 122 | 214, 220, 292, 436 | 355.0454 | C18H11O8 | 0.7 | 0.8 | 0.3 | Asai et al., |
| 2 | 11.22 | 9,12,13-Trihydroxy-10-octadecenoic acid (9,12,13-TriHOME) | 329 | 331 | 330 | (–)329 > 311 > 293, 275, 181,155; (+)331 > 314, 295, 226, 200, 104 | 219, 228, 274 | 329.2328 | C18H33O5 | 0.1 | −2.1 | −0.7 | Lee et al., |
| 3 | 11.30 | 9,10,13-Trihydroxy-10-octadecenoic acid (9,10,13-TriHOME) | 329 | 331 | 330 | (–)329 > 311 > 293 > 275, 249, 193 | 219, 227 | 329.2321 | C18H33O5 | 0.1 | −2.1 | −0.7 | Martin-Arjol et al., |
| 4 | 11.91 | 5,8-Dihydroxy-octadeca-9,12-dienoic acid. (5,8-DiHODE) | 311 | – | 312 | (–)311 > 293 > 275, 249 > 231, 193, 181, 165, 149; | 221 | 311.2222 | C18H31O4 | 0.5 | 0.0 | 0.0 | Garscha and Oliw, |
| 5 | 13.42 | 12, 13-Dihydroxy-octadeca-9-monoenoic acid. (12,13-DiHOME) | 313 | 315 | 314 | (–)313 > 295, 276, 201 > 277, 251, 195, 179, 171; (+)315 > 297, 279 > 277, 251 > 195, 179 > 261, 243 | 222, 231 | 313.2379 | C18H33O4 | 0.2 | −3.5 | 0.2 | Standard compound |
| 6 | 16.53 | 13-Desoxypaxilline (Indole diterpene) | 464f | 420 | 419 | (+)420 > 402 > 384, 330, 285, 238 > 182,167 | 233, 274, 487 | 418.2382 | C27H32NO3 | 0.0 | −1.9 | −0.8 | Rank et al., |
| 7 | 18.55 | 8-Hydroxy-octadeca-9-monoenoic acid, (8-HOME) Psi B - β | 297 | – | 298 | (–)297 > 279, 254, 253 > 249, 225 | 225 | 297.2430 | C18H33O3 | 0.0 | −5.4 | −1.6 | Smith et al., |
| 8 | 8.82 | N.I (1) | 321,367 f | – | 322 | (–)367 > 321 > 257 > 221,194 | 213, 273 | – | – | – | – | – | – |
| 9 | 9.05 | N.I (2) | 199 | – | 200 | (–)199 > 181,155, 137, 127 | 213, 269, 320 | – | – | – | – | – | – |
| 10 | 9.55 | N.I (3) | 373 | – | 374 | (–)373 > 355, 315 > 313, 287 > 259, 243, 215; | 215, 291, 366 | 373.0560 | – | – | – | – | – |
| 11 | 10.92 | N.I (4) | 464 | 466 | 465 | (–)464 > 402, 420, 446 > 398, 382, 353 > 366, 351, 314, 298 (+)466 > 448, 430, 412, 355 | 219, 226, 291 | 464.2473 | – | – | – | – | – |
| 12 | 11.10 | N.I (5) | 357 | – | 358 | (–)357 > 339, 299 > 339, 321, 297 > 253 | 219, 277, 288 | 357.0610 | – | – | – | – | – |
| 13 | 11.59 | N.I (6) | 329, 659 | 331, 661 | 330 | (–)659 > 329 (+)661 > 642, 643 | 220 | 329.0661 | – | – | – | – | – |
| 14 | 12.38 | N.I (7) | 339 | 341 | 340 | (–)339 > 297, 321, 339 > 293, 275, 231, 187 | 221, 230 | 339.0505 | – | – | – | – | – |
| 15 | 12.57 | N.I (8) | 448 | 450 | 449 | (–)448 > 404 (+)450 > 432, 414 | 222 | – | – | – | – | – | – |
RT, Retention time for chromatographic elution; f: [M+FA–H], where FA: Formate adduct; S1.
HS-SPME-GC-TOF-MS analysis of putatively identified headspace VOCs for 7 days incubated experimental (S1VMI:S2) and respective control (S1 and S2), strains of A. oryzae.
| 1 | 1.28 ± 0.14 | Hexanal | 44, 56, 41, 57, 43, 39, 72 | 44 | N.D | N.D | 0.0076 ± 0.003 | NIST | Aldehyde |
| 2 | 1.31 ± 0.15 | N.I. 1 | 44, 207, 96, 208, 209, 191, 133 | 207 | 0.04 ± 0.0085 | N.D | N.D | N.D | N.A |
| 3 | 4.84 ± 0.57 | Ethenyl benzene | 104, 78, 103, 77, 51, 44, 52 | 104 | N.D | N.D | 0.0011 ± 0.0008 | Wiley 9 | Aryl alkenes |
| 4 | 10.41 ± 0.31 | Benzaldehyde | 77, 105, 106, 51, 50, 78 52 | 77 | N.D | N.D | 0.018 ± 0.0022 | NIST | Aldehyde |
| 5 | 11.37 ± 0.19 | (5Z)-Octa-1,5-dien-3-ol | 57, 55, 41,70, 39, 42, 69 | 57 | 0.29 ± 0.11 | 0.0043 ± 0.0013 | 0.063 ± 0.004 | Wiley 9 | Alcohol |
| 6 | 11.71 ± 0.10 | 1-Octen-3-ol | 57, 43, 72, 41, 55, 39, 58 | 57 | 15.38 ± 7.15 | 0.54 ± 0.18 | 4.02 ± 0.0054 | Wiley 9 VOC BinBase | Alcohol |
| 7 | 11.93 ± 0.014 | 3-Octanone | 57, 43, 72, 99, 41, 71, 55 | 99 | 0.046 ± 0.032 | N.D | 0.024 ± 0.0045 | NIST | Ketone |
| 8 | 12.10 ± 0.19 | 7-methyl-3-methylideneocta-1,6-diene | 41, 93, 69, 57, 91, 39, 77 | 93 | N.D | 0.0054 ± 0.0018 | 0.003 ± 0.00022 | NIST/VOC BinBase | Alkene |
| 9 | 12.34 ± 0.50 | N.I. 2 | 57, 41, 43, 93, 69, 55, 39 | 57 | N.D | N.D | 0.000544 ± 0.0001 | N.D | N.A |
| 10 | 12.58 ± 0.16 | Octanal | 44, 57, 41, 43, 55, 56, 42 | 56 | N.D | N.D | 0.0051 ± 0.00054 | Wiley 9 | Aldehyde |
| 11 | 12.67 ± 0.077 | N.I. 3 | 281, 282, 283, 265, 133, 249, 73 | 281 | 0.14 ± 0.0037 | 0.0043 ± 0.0018 | N.D | N.D | N.A |
| 12 | 13.98 ± 0.09 | Benzene acetaldehyde | 91, 92, 65, 120, 39, 51, 63 | 91 | N.D | N.D | 0.020 ± 0.017 | Wiley 9 | Aryl aldehyde |
| 13 | 14.57 ± 0.041 | 2-octenal | 41, 55, 70, 57, 39, 83, 42 | 55 | 0.23 ± 0.035 | 0.022 ± 0.011 | 0.015 ± 0.0021 | Wiley 9 | Aldehyde |
| 14 | 15.17 ± 0.10 | 1-Octanol | 56, 55, 41, 43, 69, 42, 70 | 56 | N.D | N.D | 0.070 ± 0.0082 | NIST | Alcohol |
| 15 | 16.42 ± 0.095 | Linalool | 71, 43, 93, 41, 55, 69, 80 | 71 | 1.016 ± 0.022 | 1.0 ± 2.54 × 10−7 | 1.0 ± 1.59 × 10−7 | IS | Terpene alcohol |
| 16 | 17.14 ± 0.14 | 1-octen-3-yl acetate | 43, 54, 99, 67, 41, 39, 55 | 99 | 0.0043 ± 0.00082 | 0.0034 ± 0.00037 | N.D | NIST | Ester |
RT, Retention time; VOCs, Volatile organic compounds; UM, Unique mass; N.I, Not identified; N.D, Not determined; NIST, National Institute of Standards and Technology; Wiley 9, Wiley Registry of Mass Spectral Data, 9th edition; S1.